Latest Manufacturing News

Tivan Limited’s Stage Two drilling at the Sandover Fluorite Project delivers broad, high-grade fluorite intersections up to 74.3% CaF2, validating exploration models and setting the stage for a maiden resource estimate.

Tungsten Mining’s Mt Mulgine Pre-Feasibility Study reveals a 21-year mine life with A$6.8 billion pre-tax NPV and production starting in 2029, positioning it as the globe’s most competitive tungsten operation.

Sparc Technologies has made its inaugural commercial delivery of ecosparc®, a graphene additive, to a major coatings manufacturer, underpinning its push to dominate the protective coatings market. The company also launched a discounted Share Purchase Plan to fuel ongoing commercial expansion.

American Tungsten & Antimony has commissioned Metso Finland to conduct a concept-level study for expanding ammonium paratungstate production at its Nevada Del Sol Refinery, aiming to bolster US domestic tungsten supply amid national security concerns.

Pure Foods Tasmania reports a modest revenue dip but boosts gross profit and margin in FY26, while statutory losses swell due to non-cash accounting adjustments and strategic realignment.

DGL Group's FY26 results show a $5.8 million underlying loss amid investments in manufacturing and logistics capacity, with the company targeting margin improvements through better utilisation and cost control in FY27.

Vmoto Limited posted its strongest half-year sales ever with $35.7 million revenue and a 140% surge in unit sales, underpinned by new global partnerships and international market growth.

NOVONIX Limited posted a $24.6 million half-year loss while delivering a critical synthetic graphite sample to Panasonic and reaffirming a 2027 production start. The company raised $21.7 million to fund its North American battery materials expansion amid ongoing U.S. trade and policy developments.

Advance ZincTek posted an 11% rise in FY26 profit before tax to $2.247 million on 12.6% higher sales, driven by AI integration and US market strength. The company is set to enter residential battery manufacturing in FY27, leveraging its zinc oxide expertise.

Orthocell posts record FY26 revenue growth driven by expanding US and international sales of its collagen medical devices, while investing ahead in manufacturing capacity and product pipeline.

BLS Pharmaceuticals (ASX: BLS) reported a standout FY26 with revenue surging 161% to $74.2 million and net profit more than tripling to $15.4 million, driven by expanded manufacturing and major international contracts including a $50 million German supply deal.

The Calmer Co. International Limited posted a record $8.1 million revenue for FY26, driven by retail and wholesale growth, yet recorded a $3.8 million net loss amid ongoing funding challenges and strategic investments.